The company's purpose is to conduct research, development, manufacturing, and distribution in the field of pharmaceutical, chemical, medical-technical, biotechnological, and related products, as well as to provide related services. The company may establish branches and subsidiaries in Switzerland and/or abroad, participate in other companies in Switzerland and/or abroad, acquire, hold, encumber, and sell real estate and intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, on a paid or unpaid basis, and provide security of any kind for the liabilities of such persons or group companies, including guarantees, pledges, and fiduciary transfers of the company's assets. Additionally, it may engage in liquidity balancing/net liquidity centralization (cash pooling), including periodic balance adjustments, with group companies, either without consideration, on preferential terms, interest-free, excluding its profit-making intention, and assuming bulk risks.
Outbound Leads by COHAGA